Berkeley, Inc Pfizer Inc Transaction History

Berkeley, Inc

$193 Billion
Q4 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Mar 04, 2025	SELL	$26.13 - $33.94 $671,070 - $871,647	-25,682 Closed	0 $0
Q3 2023 Mar 28, 2025	BUY	$32.09 - $37.51 $39,053 - $45,649	1,217 Added 4.97%	25,682 $852 Million
Q3 2023 Mar 04, 2025	BUY	$32.09 - $37.51 $39,053 - $45,649	1,217 Added 4.97%	25,682 $852 Million
Q2 2023 Mar 28, 2025	BUY	$36.12 - $41.79 $33,952 - $39,282	940 Added 4.0%	24,465 $897 Million
Q2 2023 Mar 04, 2025	BUY	$36.12 - $41.79 $33,952 - $39,282	940 Added 4.0%	24,465 $897 Million
Q1 2023 Mar 28, 2025	BUY	$39.39 - $51.28 $36,120 - $47,023	917 Added 4.06%	23,525 $960 Million
Q1 2023 Mar 04, 2025	BUY	$39.39 - $51.28 $36,120 - $47,023	917 Added 4.06%	23,525 $960 Million
Q4 2022 Mar 28, 2025	BUY	$41.75 - $54.5 $943,884 - $1.23 Million	22,608 New	22,608 $1.16 Billion
Q4 2022 Mar 04, 2025	SELL	$41.75 - $54.5 $104,124 - $135,923	-2,494 Reduced 9.94%	22,608 $1.16 Billion
Q3 2022 Mar 28, 2025	SELL	$43.76 - $53.42 $168,694 - $205,934	-3,855 Reduced 13.31%	25,102 $1.1 Billion
Q3 2022 Mar 04, 2025	SELL	$43.76 - $53.42 $168,694 - $205,934	-3,855 Reduced 13.31%	25,102 $1.1 Billion
Q2 2022 Mar 28, 2025	BUY	$46.53 - $55.17 $1.09 Million - $1.29 Million	23,340 Added 415.52%	28,957 $1.52 Billion
Q2 2022 Mar 04, 2025	BUY	$46.53 - $55.17 $1.09 Million - $1.29 Million	23,340 Added 415.52%	28,957 $1.52 Billion
Q1 2022 Mar 28, 2025	SELL	$45.75 - $56.69 $1,692 - $2,097	-37 Reduced 0.65%	5,617 $291 Million
Q1 2022 Mar 04, 2025	SELL	$45.75 - $56.69 $1,692 - $2,097	-37 Reduced 0.65%	5,617 $291 Million
Q4 2021 Mar 28, 2025	BUY	$41.32 - $61.25 $1,033 - $1,531	25 Added 0.44%	5,654 $334 Million
Q4 2021 Mar 04, 2025	BUY	$41.32 - $61.25 $1,033 - $1,531	25 Added 0.44%	5,654 $334 Million
Q3 2021 Mar 28, 2025	BUY	$39.25 - $50.42 $1,138 - $1,462	29 Added 0.52%	5,629 $242 Million
Q3 2021 Mar 04, 2025	BUY	$39.25 - $50.42 $1,138 - $1,462	29 Added 0.52%	5,629 $242 Million
Q2 2021 Mar 28, 2025	SELL	$35.91 - $40.68 $306,671 - $347,407	-8,540 Reduced 60.4%	5,600 $219 Million
Q2 2021 Mar 04, 2025	SELL	$35.91 - $40.68 $306,671 - $347,407	-8,540 Reduced 60.4%	5,600 $219 Million
Q1 2021 Mar 28, 2025	BUY	$33.49 - $37.77 $473,548 - $534,067	14,140 New	14,140 $512 Million
Q1 2021 Mar 04, 2025	BUY	$33.49 - $37.77 $473,548 - $534,067	14,140 New	14,140 $512 Million

Others Institutions Holding PFE

# of Institutions

3,361

Shares Held

3.56B

Call Options Held

106M

Put Options Held

123M

Vanguard Group Inc Valley Forge, PA

519M
Shares

$11.8 Billion
0.25% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$9.67 Billion
0.27% of portfolio
State Street Corp Boston, MA

290M
Shares

$6.62 Billion
0.31% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

155M
Shares

$3.54 Billion
0.78% of portfolio
Geode Capital Management, LLC Boston, MA

121M
Shares

$2.75 Billion
0.25% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $128B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Berkeley, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Berkeley, Inc with notifications on news.

Account